Indaptus Therapeutics Statistics
Share Statistics
Indaptus Therapeutics has 12.01M shares outstanding. The number of shares has increased by 40.7% in one year.
| Shares Outstanding | 12.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 17.82% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.25M |
| Failed to Deliver (FTD) Shares | 582 |
| FTD / Avg. Volume | 0.49% |
Short Selling Information
The latest short interest is 138.70K, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 138.70K |
| Short % of Shares Out | 1.15% |
| Short % of Float | 1.5% |
| Short Ratio (days to cover) | 0.54 |
Valuation Ratios
The PE ratio is -0.96 and the forward PE ratio is -0.83.
| PE Ratio | -0.96 |
| Forward PE | -0.83 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.22 |
| P/FCF Ratio | -1.1 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Indaptus Therapeutics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.05, with a Debt / Equity ratio of 0.
| Current Ratio | 5.05 |
| Quick Ratio | 5.05 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.28% and return on capital (ROIC) is -133.68%.
| Return on Equity (ROE) | -1.28% |
| Return on Assets (ROA) | -1.03% |
| Return on Capital (ROIC) | -133.68% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.20M |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -49.15% in the last 52 weeks. The beta is 1.13, so Indaptus Therapeutics 's price volatility has been higher than the market average.
| Beta | 1.13 |
| 52-Week Price Change | -49.15% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 44.14 |
| Average Volume (20 Days) | 117.74K |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.28K |
| Operating Income | -16.38M |
| Net Income | -15.42M |
| EBITDA | -16.38M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.84 |
Balance Sheet
The company has 13.36M in cash and 175.05K in debt, giving a net cash position of 13.19M.
| Cash & Cash Equivalents | 13.36M |
| Total Debt | 175.05K |
| Net Cash | 13.19M |
| Retained Earnings | -45.42M |
| Total Assets | 8.24M |
| Working Capital | 5.40M |
Cash Flow
In the last 12 months, operating cash flow was -13.41M and capital expenditures 0, giving a free cash flow of -13.41M.
| Operating Cash Flow | -13.41M |
| Capital Expenditures | 0 |
| Free Cash Flow | -13.41M |
| FCF Per Share | -1.6 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -204.44% |
| FCF Yield | -123.98% |
Analyst Forecast
The average price target for INDP is $8.5, which is 844.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.5 |
| Price Target Difference | 844.4% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Jul 27, 2021. It was a backward split with a ratio of 1:4.
| Last Split Date | Jul 27, 2021 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | -11.88 |
| Piotroski F-Score | 2 |